| Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020 | 555 | 2020 |
| Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ... Science Translational Medicine 12 (524), 2020 | 451 | 2020 |
| Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet Neurology 20 (9), 739-752, 2021 | 279 | 2021 |
| Targeting neuroinflammation to treat Alzheimer’s disease A Ardura-Fabregat, E Boddeke, A Boza-Serrano, S Brioschi, ... CNS drugs 31 (12), 1057-1082, 2017 | 243 | 2017 |
| Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia MA Santos-Santos, GD Rabinovici, L Iaccarino, N Ayakta, G Tammewar, ... JAMA neurology 75 (3), 342-352, 2018 | 221* | 2018 |
| Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission … R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ... JAMA neurology 78 (8), 961-971, 2021 | 186 | 2021 |
| Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease L Iaccarino, G Tammewar, N Ayakta, SL Baker, A Bejanin, AL Boxer, ... NeuroImage: Clinical 17, 452-464, 2018 | 165 | 2018 |
| 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases DN Soleimani-Meigooni, L Iaccarino, R La Joie, S Baker, V Bourakova, ... Brain 143 (11), 3477-3494, 2020 | 113 | 2020 |
| Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau-and amyloid-PET R La Joie, AV Visani, OH Lesman-Segev, SL Baker, L Edwards, ... Neurology 96 (5), e650-e661, 2021 | 88 | 2021 |
| Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging C Cerami, L Iaccarino, D Perani International Journal of Molecular Sciences 18 (5), 993, 2017 | 86 | 2017 |
| Association between ambient air pollution and amyloid positron emission tomography positivity in older adults with cognitive impairment L Iaccarino, R La Joie, OH Lesman-Segev, E Lee, L Hanna, IE Allen, ... JAMA neurology 78 (2), 197-207, 2021 | 83 | 2021 |
| Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain R Ossenkoppele, L Iaccarino, DR Schonhaut, JA Brown, R La Joie, ... NeuroImage: Clinical 23, 101848, 2019 | 83 | 2019 |
| A Survey of FDG-and Amyloid-PET Imaging in Dementia and GRADE Analysis D Perani, O Schillaci, A Padovani, FM Nobili, L Iaccarino, PA Della Rosa, ... BioMed Research International 2014, 2014 | 78* | 2014 |
| Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria SP Caminiti, A Sala, L Iaccarino, L Beretta, A Pilotto, L Gianolli, ... Alzheimer's research & therapy 11, 1-14, 2019 | 75 | 2019 |
| Neurophysiological signatures in Alzheimer’s disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline KG Ranasinghe, J Cha, L Iaccarino, LB Hinkley, AJ Beagle, J Pham, ... Science Translational Medicine 12 (534), 2020 | 74 | 2020 |
| Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease T Ballarini, L Iaccarino, G Magnani, N Ayakta, BL Miller, WJ Jagust, ... Human Brain Mapping, 2016 | 72 | 2016 |
| Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and … EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nat Med 26 (3), 387-397, 2020 | 71 | 2020 |
| A Cross-Validation of FDG-and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer’s Disease in a Clinical Setting L Iaccarino, K Chiotis, P Alongi, O Almkvist, A Wall, C Cerami, V Bettinardi, ... Journal of Alzheimer's Disease, 1-12, 2017 | 69 | 2017 |
| Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration N Mattsson-Carlgren, LT Grinberg, A Boxer, R Ossenkoppele, M Jonsson, ... Neurology, 2022 | 66 | 2022 |
| The semantic variant of primary progressive aphasia: clinical and neuroimaging evidence in single subjects. L Iaccarino, C Crespi, PA Della Rosa, E Catricalà, L Guidi, A Marcone, ... PloS one 10 (3), e0120197, 2015 | 62 | 2015 |
Gil Rabinovici在 ucsf.edu 的电子邮件经过验证
Gil Rabinovici在 ucsf.edu 的电子邮件经过验证
Renaud La JoieMemory and Aging Center; Department of Neurology; University of California, San Francisco在 ucsf.edu 的电子邮件经过验证